Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Sleeplessness and Circadian Rhythm Disorder Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Sleeplessness and Circadian Rhythm Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Sleeplessness and Circadian Rhythm Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Sleeplessness and Circadian Rhythm Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Sleeplessness and Circadian Rhythm Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Sleeplessness and Circadian Rhythm Disorder Treatment players cover Lanaform, Compass Health Brands (Carex Health), Compumedics, Natus Medical and Teva Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Sleeplessness and Circadian Rhythm Disorder Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Sleeplessness and Circadian Rhythm Disorder Treatment market, with both quantitative and qualitative data, to help readers understand how the Sleeplessness and Circadian Rhythm Disorder Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Sleeplessness and Circadian Rhythm Disorder Treatment market and forecasts the market size by Type (Drug Therapy and Light Therapy,), by Application (Hospital, Specialist Clinic and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Sleeplessness and Circadian Rhythm Disorder Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Sleeplessness and Circadian Rhythm Disorder Treatment market size and CAGR, Sleeplessness and Circadian Rhythm Disorder Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Sleeplessness and Circadian Rhythm Disorder Treatment revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Sleeplessness and Circadian Rhythm Disorder Treatment revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Sleeplessness and Circadian Rhythm Disorder Treatment market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Lanaform, Compass Health Brands (Carex Health), Compumedics, Natus Medical, Teva Pharmaceuticals, Lucimed (Luminette), Garmin, Koninklijke Philips and Mylan, etc.
Chapter 14: Research Findings and Conclusion
The global market for Sleeplessness and Circadian Rhythm Disorder Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Sleeplessness and Circadian Rhythm Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Sleeplessness and Circadian Rhythm Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Sleeplessness and Circadian Rhythm Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Sleeplessness and Circadian Rhythm Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Sleeplessness and Circadian Rhythm Disorder Treatment players cover Lanaform, Compass Health Brands (Carex Health), Compumedics, Natus Medical and Teva Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Sleeplessness and Circadian Rhythm Disorder Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Sleeplessness and Circadian Rhythm Disorder Treatment market, with both quantitative and qualitative data, to help readers understand how the Sleeplessness and Circadian Rhythm Disorder Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Sleeplessness and Circadian Rhythm Disorder Treatment market and forecasts the market size by Type (Drug Therapy and Light Therapy,), by Application (Hospital, Specialist Clinic and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Drug Therapy
- Light Therapy
- Hospital
- Specialist Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lanaform
- Compass Health Brands (Carex Health)
- Compumedics
- Natus Medical
- Teva Pharmaceuticals
- Lucimed (Luminette)
- Garmin
- Koninklijke Philips
- Mylan
- Fitbit
- Takeda Pharmaceutical
- F.Hoffman La-Roche AG
- Merck & Co. Inc.
- Pfizer, Inc.
- Pernix Therapeutics
- Sanofi S.A.
- Sumitomo Dainippon Pharma Co., Ltd
- Vanda Pharmaceuticals, Inc.
Chapter 1: Scope of Sleeplessness and Circadian Rhythm Disorder Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Sleeplessness and Circadian Rhythm Disorder Treatment market size and CAGR, Sleeplessness and Circadian Rhythm Disorder Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Sleeplessness and Circadian Rhythm Disorder Treatment revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Sleeplessness and Circadian Rhythm Disorder Treatment revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Sleeplessness and Circadian Rhythm Disorder Treatment market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Lanaform, Compass Health Brands (Carex Health), Compumedics, Natus Medical, Teva Pharmaceuticals, Lucimed (Luminette), Garmin, Koninklijke Philips and Mylan, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2017-2028
2.1.2 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Sleeplessness and Circadian Rhythm Disorder Treatment Segment by Type
2.2.1 Drug Therapy
2.2.2 Light Therapy
2.3 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type
2.3.1 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type (2017-2022)
2.4 Sleeplessness and Circadian Rhythm Disorder Treatment Segment by Application
2.4.1 Hospital
2.4.2 Specialist Clinic
2.4.3 Others
2.5 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application
2.5.1 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application (2017-2022)
3 SLEEPLESSNESS AND CIRCADIAN RHYTHM DISORDER TREATMENT MARKET SIZE BY PLAYER
3.1 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Players
3.1.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue by Players (2020-2022)
3.1.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SLEEPLESSNESS AND CIRCADIAN RHYTHM DISORDER TREATMENT BY REGIONS
4.1 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Regions (2017-2022)
4.2 Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth (2017-2022)
4.3 APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth (2017-2022)
4.4 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022)
5.2 Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022)
5.3 Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2017-2022)
6.2 APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022)
6.3 APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sleeplessness and Circadian Rhythm Disorder Treatment by Country (2017-2022)
7.2 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022)
7.3 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment by Region (2017-2022)
8.2 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SLEEPLESSNESS AND CIRCADIAN RHYTHM DISORDER TREATMENT MARKET FORECAST
10.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Regions (2023-2028)
10.1.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Sleeplessness and Circadian Rhythm Disorder Treatment Forecast
10.1.3 APAC Sleeplessness and Circadian Rhythm Disorder Treatment Forecast
10.1.4 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Forecast
10.1.5 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Forecast
10.2 Americas Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Country (2023-2028)
10.2.1 United States Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.2.2 Canada Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.2.3 Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.2.4 Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.3 APAC Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Region (2023-2028)
10.3.1 China Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.3.2 Japan Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.3.3 Korea Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.3.4 Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.3.5 India Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.3.6 Australia Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.4 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Country (2023-2028)
10.4.1 Germany Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.4.2 France Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.4.3 UK Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.4.4 Italy Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.4.5 Russia Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.5 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.5.2 South Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.5.3 Israel Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.5.4 Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.5.5 GCC Countries Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.6 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Type (2023-2028)
10.7 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Lanaform
11.1.1 Lanaform Company Information
11.1.2 Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.1.3 Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Lanaform Main Business Overview
11.1.5 Lanaform Latest Developments
11.2 Compass Health Brands (Carex Health)
11.2.1 Compass Health Brands (Carex Health) Company Information
11.2.2 Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.2.3 Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Compass Health Brands (Carex Health) Main Business Overview
11.2.5 Compass Health Brands (Carex Health) Latest Developments
11.3 Compumedics
11.3.1 Compumedics Company Information
11.3.2 Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.3.3 Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Compumedics Main Business Overview
11.3.5 Compumedics Latest Developments
11.4 Natus Medical
11.4.1 Natus Medical Company Information
11.4.2 Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.4.3 Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Natus Medical Main Business Overview
11.4.5 Natus Medical Latest Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Information
11.5.2 Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.5.3 Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Teva Pharmaceuticals Main Business Overview
11.5.5 Teva Pharmaceuticals Latest Developments
11.6 Lucimed (Luminette)
11.6.1 Lucimed (Luminette) Company Information
11.6.2 Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.6.3 Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Lucimed (Luminette) Main Business Overview
11.6.5 Lucimed (Luminette) Latest Developments
11.7 Garmin
11.7.1 Garmin Company Information
11.7.2 Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.7.3 Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Garmin Main Business Overview
11.7.5 Garmin Latest Developments
11.8 Koninklijke Philips
11.8.1 Koninklijke Philips Company Information
11.8.2 Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.8.3 Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Koninklijke Philips Main Business Overview
11.8.5 Koninklijke Philips Latest Developments
11.9 Mylan
11.9.1 Mylan Company Information
11.9.2 Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.9.3 Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Mylan Main Business Overview
11.9.5 Mylan Latest Developments
11.10 Fitbit
11.10.1 Fitbit Company Information
11.10.2 Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.10.3 Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Fitbit Main Business Overview
11.10.5 Fitbit Latest Developments
11.11 Takeda Pharmaceutical
11.11.1 Takeda Pharmaceutical Company Information
11.11.2 Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.11.3 Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Takeda Pharmaceutical Main Business Overview
11.11.5 Takeda Pharmaceutical Latest Developments
11.12 F.Hoffman La-Roche AG
11.12.1 F.Hoffman La-Roche AG Company Information
11.12.2 F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.12.3 F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 F.Hoffman La-Roche AG Main Business Overview
11.12.5 F.Hoffman La-Roche AG Latest Developments
11.13 Merck & Co. Inc.
11.13.1 Merck & Co. Inc. Company Information
11.13.2 Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.13.3 Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Merck & Co. Inc. Main Business Overview
11.13.5 Merck & Co. Inc. Latest Developments
11.14 Pfizer, Inc.
11.14.1 Pfizer, Inc. Company Information
11.14.2 Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.14.3 Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Pfizer, Inc. Main Business Overview
11.14.5 Pfizer, Inc. Latest Developments
11.15 Pernix Therapeutics
11.15.1 Pernix Therapeutics Company Information
11.15.2 Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.15.3 Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Pernix Therapeutics Main Business Overview
11.15.5 Pernix Therapeutics Latest Developments
11.16 Sanofi S.A.
11.16.1 Sanofi S.A. Company Information
11.16.2 Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.16.3 Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Sanofi S.A. Main Business Overview
11.16.5 Sanofi S.A. Latest Developments
11.17 Sumitomo Dainippon Pharma Co., Ltd
11.17.1 Sumitomo Dainippon Pharma Co., Ltd Company Information
11.17.2 Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.17.3 Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Sumitomo Dainippon Pharma Co., Ltd Main Business Overview
11.17.5 Sumitomo Dainippon Pharma Co., Ltd Latest Developments
11.18 Vanda Pharmaceuticals, Inc.
11.18.1 Vanda Pharmaceuticals, Inc. Company Information
11.18.2 Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.18.3 Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Vanda Pharmaceuticals, Inc. Main Business Overview
11.18.5 Vanda Pharmaceuticals, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2017-2028
2.1.2 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Sleeplessness and Circadian Rhythm Disorder Treatment Segment by Type
2.2.1 Drug Therapy
2.2.2 Light Therapy
2.3 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type
2.3.1 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type (2017-2022)
2.4 Sleeplessness and Circadian Rhythm Disorder Treatment Segment by Application
2.4.1 Hospital
2.4.2 Specialist Clinic
2.4.3 Others
2.5 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application
2.5.1 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application (2017-2022)
3 SLEEPLESSNESS AND CIRCADIAN RHYTHM DISORDER TREATMENT MARKET SIZE BY PLAYER
3.1 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Players
3.1.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue by Players (2020-2022)
3.1.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SLEEPLESSNESS AND CIRCADIAN RHYTHM DISORDER TREATMENT BY REGIONS
4.1 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Regions (2017-2022)
4.2 Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth (2017-2022)
4.3 APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth (2017-2022)
4.4 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022)
5.2 Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022)
5.3 Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2017-2022)
6.2 APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022)
6.3 APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sleeplessness and Circadian Rhythm Disorder Treatment by Country (2017-2022)
7.2 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022)
7.3 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment by Region (2017-2022)
8.2 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SLEEPLESSNESS AND CIRCADIAN RHYTHM DISORDER TREATMENT MARKET FORECAST
10.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Regions (2023-2028)
10.1.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Sleeplessness and Circadian Rhythm Disorder Treatment Forecast
10.1.3 APAC Sleeplessness and Circadian Rhythm Disorder Treatment Forecast
10.1.4 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Forecast
10.1.5 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Forecast
10.2 Americas Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Country (2023-2028)
10.2.1 United States Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.2.2 Canada Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.2.3 Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.2.4 Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.3 APAC Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Region (2023-2028)
10.3.1 China Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.3.2 Japan Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.3.3 Korea Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.3.4 Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.3.5 India Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.3.6 Australia Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.4 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Country (2023-2028)
10.4.1 Germany Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.4.2 France Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.4.3 UK Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.4.4 Italy Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.4.5 Russia Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.5 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.5.2 South Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.5.3 Israel Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.5.4 Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.5.5 GCC Countries Sleeplessness and Circadian Rhythm Disorder Treatment Market Forecast
10.6 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Type (2023-2028)
10.7 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Lanaform
11.1.1 Lanaform Company Information
11.1.2 Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.1.3 Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Lanaform Main Business Overview
11.1.5 Lanaform Latest Developments
11.2 Compass Health Brands (Carex Health)
11.2.1 Compass Health Brands (Carex Health) Company Information
11.2.2 Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.2.3 Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Compass Health Brands (Carex Health) Main Business Overview
11.2.5 Compass Health Brands (Carex Health) Latest Developments
11.3 Compumedics
11.3.1 Compumedics Company Information
11.3.2 Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.3.3 Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Compumedics Main Business Overview
11.3.5 Compumedics Latest Developments
11.4 Natus Medical
11.4.1 Natus Medical Company Information
11.4.2 Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.4.3 Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Natus Medical Main Business Overview
11.4.5 Natus Medical Latest Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Information
11.5.2 Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.5.3 Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Teva Pharmaceuticals Main Business Overview
11.5.5 Teva Pharmaceuticals Latest Developments
11.6 Lucimed (Luminette)
11.6.1 Lucimed (Luminette) Company Information
11.6.2 Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.6.3 Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Lucimed (Luminette) Main Business Overview
11.6.5 Lucimed (Luminette) Latest Developments
11.7 Garmin
11.7.1 Garmin Company Information
11.7.2 Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.7.3 Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Garmin Main Business Overview
11.7.5 Garmin Latest Developments
11.8 Koninklijke Philips
11.8.1 Koninklijke Philips Company Information
11.8.2 Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.8.3 Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Koninklijke Philips Main Business Overview
11.8.5 Koninklijke Philips Latest Developments
11.9 Mylan
11.9.1 Mylan Company Information
11.9.2 Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.9.3 Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Mylan Main Business Overview
11.9.5 Mylan Latest Developments
11.10 Fitbit
11.10.1 Fitbit Company Information
11.10.2 Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.10.3 Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Fitbit Main Business Overview
11.10.5 Fitbit Latest Developments
11.11 Takeda Pharmaceutical
11.11.1 Takeda Pharmaceutical Company Information
11.11.2 Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.11.3 Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Takeda Pharmaceutical Main Business Overview
11.11.5 Takeda Pharmaceutical Latest Developments
11.12 F.Hoffman La-Roche AG
11.12.1 F.Hoffman La-Roche AG Company Information
11.12.2 F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.12.3 F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 F.Hoffman La-Roche AG Main Business Overview
11.12.5 F.Hoffman La-Roche AG Latest Developments
11.13 Merck & Co. Inc.
11.13.1 Merck & Co. Inc. Company Information
11.13.2 Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.13.3 Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Merck & Co. Inc. Main Business Overview
11.13.5 Merck & Co. Inc. Latest Developments
11.14 Pfizer, Inc.
11.14.1 Pfizer, Inc. Company Information
11.14.2 Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.14.3 Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Pfizer, Inc. Main Business Overview
11.14.5 Pfizer, Inc. Latest Developments
11.15 Pernix Therapeutics
11.15.1 Pernix Therapeutics Company Information
11.15.2 Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.15.3 Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Pernix Therapeutics Main Business Overview
11.15.5 Pernix Therapeutics Latest Developments
11.16 Sanofi S.A.
11.16.1 Sanofi S.A. Company Information
11.16.2 Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.16.3 Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Sanofi S.A. Main Business Overview
11.16.5 Sanofi S.A. Latest Developments
11.17 Sumitomo Dainippon Pharma Co., Ltd
11.17.1 Sumitomo Dainippon Pharma Co., Ltd Company Information
11.17.2 Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.17.3 Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Sumitomo Dainippon Pharma Co., Ltd Main Business Overview
11.17.5 Sumitomo Dainippon Pharma Co., Ltd Latest Developments
11.18 Vanda Pharmaceuticals, Inc.
11.18.1 Vanda Pharmaceuticals, Inc. Company Information
11.18.2 Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
11.18.3 Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Vanda Pharmaceuticals, Inc. Main Business Overview
11.18.5 Vanda Pharmaceuticals, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sleeplessness and Circadian Rhythm Disorder Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Drug Therapy
Table 3. Major Players of Light Therapy
Table 4. Sleeplessness and Circadian Rhythm Disorder Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type (2017-2022)
Table 7. Sleeplessness and Circadian Rhythm Disorder Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application (2017-2022)
Table 10. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Player (2020-2022)
Table 12. Sleeplessness and Circadian Rhythm Disorder Treatment Key Players Head office and Products Offered
Table 13. Sleeplessness and Circadian Rhythm Disorder Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Regions (2017-2022)
Table 18. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Country (2017-2022)
Table 20. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type (2017-2022)
Table 22. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application (2017-2022)
Table 24. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Region (2017-2022)
Table 26. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type (2017-2022)
Table 28. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application (2017-2022)
Table 30. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Country (2017-2022)
Table 32. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type (2017-2022)
Table 34. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Sleeplessness and Circadian Rhythm Disorder Treatment
Table 43. Key Market Challenges & Risks of Sleeplessness and Circadian Rhythm Disorder Treatment
Table 44. Key Industry Trends of Sleeplessness and Circadian Rhythm Disorder Treatment
Table 45. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 51. Lanaform Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 52. Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 53. Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Lanaform Main Business
Table 55. Lanaform Latest Developments
Table 56. Compass Health Brands (Carex Health) Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 57. Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 58. Compass Health Brands (Carex Health) Main Business
Table 59. Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Compass Health Brands (Carex Health) Latest Developments
Table 61. Compumedics Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 62. Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 63. Compumedics Main Business
Table 64. Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Compumedics Latest Developments
Table 66. Natus Medical Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 67. Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 68. Natus Medical Main Business
Table 69. Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Natus Medical Latest Developments
Table 71. Teva Pharmaceuticals Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 72. Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 73. Teva Pharmaceuticals Main Business
Table 74. Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Teva Pharmaceuticals Latest Developments
Table 76. Lucimed (Luminette) Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 77. Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 78. Lucimed (Luminette) Main Business
Table 79. Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Lucimed (Luminette) Latest Developments
Table 81. Garmin Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 82. Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 83. Garmin Main Business
Table 84. Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Garmin Latest Developments
Table 86. Koninklijke Philips Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 87. Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 88. Koninklijke Philips Main Business
Table 89. Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Koninklijke Philips Latest Developments
Table 91. Mylan Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 92. Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 93. Mylan Main Business
Table 94. Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Mylan Latest Developments
Table 96. Fitbit Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 97. Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 98. Fitbit Main Business
Table 99. Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Fitbit Latest Developments
Table 101. Takeda Pharmaceutical Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 102. Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 103. Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Takeda Pharmaceutical Main Business
Table 105. Takeda Pharmaceutical Latest Developments
Table 106. F.Hoffman La-Roche AG Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 107. F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 108. F.Hoffman La-Roche AG Main Business
Table 109. F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. F.Hoffman La-Roche AG Latest Developments
Table 111. Merck & Co. Inc. Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 112. Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 113. Merck & Co. Inc. Main Business
Table 114. Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Merck & Co. Inc. Latest Developments
Table 116. Pfizer, Inc. Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 117. Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 118. Pfizer, Inc. Main Business
Table 119. Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Pfizer, Inc. Latest Developments
Table 121. Pernix Therapeutics Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 122. Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 123. Pernix Therapeutics Main Business
Table 124. Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Pernix Therapeutics Latest Developments
Table 126. Sanofi S.A. Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 127. Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 128. Sanofi S.A. Main Business
Table 129. Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Sanofi S.A. Latest Developments
Table 131. Sumitomo Dainippon Pharma Co., Ltd Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 132. Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 133. Sumitomo Dainippon Pharma Co., Ltd Main Business
Table 134. Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Sumitomo Dainippon Pharma Co., Ltd Latest Developments
Table 136. Vanda Pharmaceuticals, Inc. Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 137. Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 138. Vanda Pharmaceuticals, Inc. Main Business
Table 139. Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. Vanda Pharmaceuticals, Inc. Latest Developments
Table 1. Sleeplessness and Circadian Rhythm Disorder Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Drug Therapy
Table 3. Major Players of Light Therapy
Table 4. Sleeplessness and Circadian Rhythm Disorder Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type (2017-2022)
Table 7. Sleeplessness and Circadian Rhythm Disorder Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application (2017-2022)
Table 10. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Player (2020-2022)
Table 12. Sleeplessness and Circadian Rhythm Disorder Treatment Key Players Head office and Products Offered
Table 13. Sleeplessness and Circadian Rhythm Disorder Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Regions (2017-2022)
Table 18. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Country (2017-2022)
Table 20. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type (2017-2022)
Table 22. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application (2017-2022)
Table 24. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Region (2017-2022)
Table 26. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type (2017-2022)
Table 28. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application (2017-2022)
Table 30. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Country (2017-2022)
Table 32. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type (2017-2022)
Table 34. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Sleeplessness and Circadian Rhythm Disorder Treatment
Table 43. Key Market Challenges & Risks of Sleeplessness and Circadian Rhythm Disorder Treatment
Table 44. Key Industry Trends of Sleeplessness and Circadian Rhythm Disorder Treatment
Table 45. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 51. Lanaform Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 52. Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 53. Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Lanaform Main Business
Table 55. Lanaform Latest Developments
Table 56. Compass Health Brands (Carex Health) Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 57. Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 58. Compass Health Brands (Carex Health) Main Business
Table 59. Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Compass Health Brands (Carex Health) Latest Developments
Table 61. Compumedics Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 62. Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 63. Compumedics Main Business
Table 64. Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Compumedics Latest Developments
Table 66. Natus Medical Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 67. Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 68. Natus Medical Main Business
Table 69. Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Natus Medical Latest Developments
Table 71. Teva Pharmaceuticals Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 72. Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 73. Teva Pharmaceuticals Main Business
Table 74. Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Teva Pharmaceuticals Latest Developments
Table 76. Lucimed (Luminette) Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 77. Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 78. Lucimed (Luminette) Main Business
Table 79. Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Lucimed (Luminette) Latest Developments
Table 81. Garmin Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 82. Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 83. Garmin Main Business
Table 84. Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Garmin Latest Developments
Table 86. Koninklijke Philips Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 87. Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 88. Koninklijke Philips Main Business
Table 89. Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Koninklijke Philips Latest Developments
Table 91. Mylan Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 92. Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 93. Mylan Main Business
Table 94. Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Mylan Latest Developments
Table 96. Fitbit Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 97. Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 98. Fitbit Main Business
Table 99. Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Fitbit Latest Developments
Table 101. Takeda Pharmaceutical Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 102. Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 103. Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Takeda Pharmaceutical Main Business
Table 105. Takeda Pharmaceutical Latest Developments
Table 106. F.Hoffman La-Roche AG Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 107. F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 108. F.Hoffman La-Roche AG Main Business
Table 109. F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. F.Hoffman La-Roche AG Latest Developments
Table 111. Merck & Co. Inc. Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 112. Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 113. Merck & Co. Inc. Main Business
Table 114. Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Merck & Co. Inc. Latest Developments
Table 116. Pfizer, Inc. Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 117. Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 118. Pfizer, Inc. Main Business
Table 119. Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Pfizer, Inc. Latest Developments
Table 121. Pernix Therapeutics Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 122. Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 123. Pernix Therapeutics Main Business
Table 124. Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Pernix Therapeutics Latest Developments
Table 126. Sanofi S.A. Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 127. Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 128. Sanofi S.A. Main Business
Table 129. Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Sanofi S.A. Latest Developments
Table 131. Sumitomo Dainippon Pharma Co., Ltd Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 132. Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 133. Sumitomo Dainippon Pharma Co., Ltd Main Business
Table 134. Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Sumitomo Dainippon Pharma Co., Ltd Latest Developments
Table 136. Vanda Pharmaceuticals, Inc. Details, Company Type, Sleeplessness and Circadian Rhythm Disorder Treatment Area Served and Its Competitors
Table 137. Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offered
Table 138. Vanda Pharmaceuticals, Inc. Main Business
Table 139. Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. Vanda Pharmaceuticals, Inc. Latest Developments
LIST OF FIGURES
LIST OF FIGURES
Figure 1. Sleeplessness and Circadian Rhythm Disorder Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type in 2021
Figure 7. Sleeplessness and Circadian Rhythm Disorder Treatment in Hospital
Figure 8. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Sleeplessness and Circadian Rhythm Disorder Treatment in Specialist Clinic
Figure 10. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market: Specialist Clinic (2017-2022) & ($ Millions)
Figure 11. Sleeplessness and Circadian Rhythm Disorder Treatment in Others
Figure 12. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application in 2021
Figure 14. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Player in 2021
Figure 15. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2017-2022 ($ Millions)
Figure 17. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Value Market Share by Country in 2021
Figure 21. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Consumption Market Share by Type in 2021
Figure 22. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application in 2021
Figure 23. United States Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Region in 2021
Figure 28. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application in 2021
Figure 29. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Country in 2021
Figure 36. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type in 2021
Figure 37. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application in 2021
Figure 38. Germany Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application in 2021
Figure 46. Egypt Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 52. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 53. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 55. United States Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Canada Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 59. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Japan Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Korea Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 63. India Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Australia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Germany Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 66. France Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 67. UK Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Italy Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Russia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Spain Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Israel Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
LIST OF FIGURES
Figure 1. Sleeplessness and Circadian Rhythm Disorder Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type in 2021
Figure 7. Sleeplessness and Circadian Rhythm Disorder Treatment in Hospital
Figure 8. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Sleeplessness and Circadian Rhythm Disorder Treatment in Specialist Clinic
Figure 10. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market: Specialist Clinic (2017-2022) & ($ Millions)
Figure 11. Sleeplessness and Circadian Rhythm Disorder Treatment in Others
Figure 12. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application in 2021
Figure 14. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Player in 2021
Figure 15. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2017-2022 ($ Millions)
Figure 17. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Value Market Share by Country in 2021
Figure 21. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Consumption Market Share by Type in 2021
Figure 22. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application in 2021
Figure 23. United States Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Region in 2021
Figure 28. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application in 2021
Figure 29. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Country in 2021
Figure 36. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type in 2021
Figure 37. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application in 2021
Figure 38. Germany Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Market Share by Application in 2021
Figure 46. Egypt Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 52. APAC Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 53. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 55. United States Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Canada Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 59. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Japan Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Korea Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 63. India Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Australia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Germany Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 66. France Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 67. UK Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Italy Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Russia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Spain Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Israel Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Sleeplessness and Circadian Rhythm Disorder Treatment Market Size 2023-2028 ($ Millions)
